Anthem (NASDAQ:ANTX) Director Margaret Fitzpatrick Purchases 2,098 Shares

Anthem, Inc. (NASDAQ:ANTX) Director Margaret Fitzpatrick bought 2,098 shares of the firm’s stock in a transaction dated Tuesday, September 1st. The stock was purchased at an average price of $5.53 per share, with a total value of $11,601.94. Following the transaction, the director owned 10,708 shares in the company, valued at approximately $59,215.24. This represents a 24.37% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.

Anthem Stock Performance

Shares of NASDAQ ANTX traded up $0.47 during trading on Wednesday, reaching $5.95. The stock had a trading volume of 350,574 shares, compared to its average volume of 682,664. The stock has a market cap of $224.55 million, a PE ratio of -5.56 and a beta of -0.99. Anthem, Inc. has a one year low of $1.00 and a one year high of $7.19. The firm’s 50 day moving average price is $5.24 and its two-hundred day moving average price is $4.24.

Anthem (NASDAQ:ANTX) last announced its quarterly earnings data on Tuesday, August 11th. The company reported ($0.18) earnings per share (EPS) for the quarter.

Hedge Funds Weigh In On Anthem

Several institutional investors have recently modified their holdings of ANTX. ADAR1 Capital Management LLC acquired a new stake in shares of Anthem in the 1st quarter worth about $47,000. OMERS ADMINISTRATION Corp bought a new stake in Anthem in the 1st quarter valued at about $54,000. Velan Capital Investment Management LP acquired a new position in Anthem during the 2nd quarter valued at about $194,000. Seven Fleet Capital Management LP acquired a new position in Anthem during the 1st quarter valued at about $683,000. Finally, Bank of America Corp DE grew its position in Anthem by 2.2% in the 1st quarter. Bank of America Corp DE now owns 393,702 shares of the company’s stock worth $1,346,000 after purchasing an additional 8,390 shares during the last quarter. Institutional investors own 90.47% of the company’s stock.

Analyst Upgrades and Downgrades

ANTX has been the topic of several research reports. Leerink Partners upgraded shares of Anthem from a “market perform” rating to an “outperform” rating and set a $9.00 price objective on the stock in a research note on Thursday, May 14th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Anthem in a report on Monday, July 6th. Guggenheim began coverage on Anthem in a research report on Monday, July 20th. They set a “buy” rating and a $9.00 price target on the stock. Finally, Wall Street Zen raised Anthem from a “sell” rating to a “hold” rating in a report on Sunday, June 14th. Two analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $9.00.

About Anthem

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.